Patents by Inventor MyIene DORVILLIUS

MyIene DORVILLIUS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190023808
    Abstract: An antibody recognizing the O-acetylated-GD2 ganglioside for the treatment of Cancer Stem Cells (CSC) cancer, a pharmaceutical composition including the antibody for treating a CSC cancer and a method for treating a CSC cancer in a patient in need thereof, the method including administering the antibody to the patient. A method for diagnosing a CSC, the use of the O-acetylated-GD2 ganglioside as a biomarker of CSC cancer, and a method for predicting the response of a subject affected with CSC cancer to a treatment with the antibody or the composition are also described.
    Type: Application
    Filed: May 21, 2018
    Publication date: January 24, 2019
    Inventors: Stephane BIRKLE, Denis COCHONNEAU, MyIene DORVILLIUS, Jean-Marc LE DOUSSAL, MickaeI TERME
  • Publication number: 20160068608
    Abstract: An antibody recognizing the O-acetylated-GD2 ganglioside for the treatment of Cancer Stem Cells (CSC) cancer, a pharmaceutical composition including the antibody for treating a CSC cancer and a method for treating a CSC cancer in a patient in need thereof, the method including administering the antibody to the patient. A method for diagnosing a CSC, the use of the O-acetylated-GD2 ganglioside as a biomarker of CSC cancer, and a method for predicting the response of a subject affected with CSC cancer to a treatment with the antibody or the composition are also described.
    Type: Application
    Filed: April 29, 2014
    Publication date: March 10, 2016
    Inventors: Stephane BIRKLE, Denis COCHONNEAU, MyIene DORVILLIUS, LE DOUSSAL Jean-Marc, MickaeI TERME